Bringing the fundamentals into focus…
Back to Azenta, Inc.
How Azenta, Inc. stacks up
AZTA · against 446 other Healthcare companies of similar size
Valuation
38/ 100
Below the middle of the pack.
Ranked #283 of 447 · scores higher than 36% of peers
Bars: peers in each 10-point band of the valuation score37 peers with a valuation score of 30–39, including AZTA · Click a bar to see the companies
Why valuation scores 38?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, which is weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -7.6% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 2.4% vs peer median 4.0%
- Free cash flow yield is close to the peer norm. Free cash flow yield: 0.6% vs peer median 0.0%
Metric by metric
Position: dot = AZTA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AZTA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 435 reported | -6.7% | 1.5% | 21% | 30% | |
| EBITDA yieldHigher is better · 448 reported | 2.4% | 4.3% | 41% | 50% | |
| Free cash flow yieldHigher is better · 202 reported | 0.6% | -0.5% | 56% | 20% | |
| Book yieldHigher is better · 437 reported | 92.9% | 37.0% | 90% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around AZTAScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score